Histone methylation driven by EZH2 has also been shown to regulate MHC-II expression in DLBCL where tumours with EZH2Y641 mutation had low expression of MHC-I and II [34]. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.